Synonym
Org-12962; Org 12962; Org12962.
IUPAC/Chemical Name
1-[6-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazine
InChi Key
QZYYPQAYSFBKPW-UHFFFAOYSA-N
InChi Code
InChI=1S/C10H11ClF3N3/c11-9-7(10(12,13)14)1-2-8(16-9)17-5-3-15-4-6-17/h1-2,15H,3-6H2
SMILES Code
FC(C1=C(Cl)N=C(N2CCNCC2)C=C1)(F)F
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Biological target:
Org-12962 is a potent, selective and orally active 5-HT2C receptor agonist with a pEC0 value of 7.01.
|
Solvent |
mg/mL |
mM |
| Solubility |
| DMSO |
250.0 |
941.04 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
265.66
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
Formulation protocol:
TBD
1: Halford JC, Harrold JA, Lawton CL, Blundell JE. Serotonin (5-HT) drugs:
effects on appetite expression and use for the treatment of obesity. Curr Drug
Targets. 2005 Mar;6(2):201-13. Review. PubMed PMID: 15777190.
2: Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR,
Sheardown MJ. Functional characterization of agonists at recombinant human
5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol. 1999
Sep;128(1):13-20. PubMed PMID: 10498829; PubMed Central PMCID: PMC1571597.
3: Jenck F, Moreau JL, Berendsen HH, Boes M, Broekkamp CL, Martin JR, Wichmann J,
Van Delft AM. Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a
model of panic-like anxiety in rats. Eur Neuropsychopharmacol. 1998
Aug;8(3):161-8. PubMed PMID: 9716307.
